T. Wanke (Wien, Austria), W. Zin (Rio De Janeiro, Brazil)
Relation between functional activity of a diaphragm and cardiohaemodynamic in patients with moderate and severe COPD E. Surkova, A. Gichkin, A. Alexandrov, V. Perley (Saint-Petersburg, Russian Federation)
| |
COPD patients under 50 years of age: 4-year follow-up in the UPLIFT trial B. Celli, S. Kesten, T. Lystig, S. Mehra, D. Tashkin, M. Decramer, A. Morice (Hull, United Kingdom; Boston, Ridgefield, New York, Los Angeles, United States Of America; Leuven, Belgium)
| |
Expiratory flow limitation and heliox breathing in resting and exercising COPD patients E. D‘Angelo, P. Santus, M. F. Civitillo, S. Centanni, M. Pecchiari (Milano, Italy)
| |
Total breath and classical diffusion capacity parameters in detecting emphysema in heavy (ex)smokers M. Marsman, H. Stam, R. van klaveren, J. W. Lammers, B. J. De Hoop, P. Zanen (Utrecht, Rotterdam, Netherlands)
| |
Reproducibility in parameters of forced inspiratory flow F. Visser, S. Ramlal, R. Dekhuijzen, Y. Heijdra (Nijmegen, Netherlands)
| |
Predicting workrate for exercise-induced asthma exercise challenge L. Ansley, M. Stone, J. Hull (Newcastle, London, United Kingdom)
| |
Correlation study of semi-quantitative CT emphysema score with the BODE index in COPD patients D. Micera, M. Bocchino, G. Rea, C. Calabrese, P. Giacomelli, A. Sanduzzi, A. Vatrella (Naples, Italy)
| |
Evaluation of dyspnea using stair climbing (SC) dyspnea scale in COPD patients F. Gomez, M. Castresana, M. D. Guerrero, G. Cueto, P. Rodriguez, M. J. Cons, R. Herrezuelo, Y. Caceres, V. Pinto-Plata (Manacor, Bunyola, Esporles, Spain; Boston, United States Of America)
| |
Effectiveness of combination therapy with tiotropium in COPD. A secondary analysis of the UPLIFT trial T. Troosters, B. Celli, S. Kesten, D. Liu, S. Mehra, D. Tashkin, M. Decramer (Leuven, Belgium; Boston, Ridgefield, New York, Los Angeles, United States Of America)
| |
Effects of diaphragm conformation on ribcage asynchronies in COPD M. Quaranta, A. Pereira de Albuquerque, P. Albert, A. Aliverti, P. Calverley (Sao Paulo, Brazil; Milano, Italy; Liverpool, United Kingdom)
| |
Estimating FEV1 and airway obstruction from tidal breathing T. Powell, P. Neill, E. M. Williams (Pontypridd, Llantrissant, United Kingdom)
| |
Quadriceps weakness in GOLD stage II COPD: data from the ECLIPSE study D. Shrikrishna, P. Albert, P. M. Calverley, M. I. Polkey, J. Seymour, M. A. Spruit, R. Tal-Singer, E. F. M. Wouters (London, Liverpool, United Kingdom; Horn, Maastricht, Netherlands; Philadelphia, United States Of America)
| |
Within-day repeatability and signal to noise ratio for IOS parameters and FEV1 in smokers with and without COPD B. Aarli, R. Jensen, T. Eagan, P. Calverley, P. Bakke, J. Hardie (Bergen, Norway; Salt Lake City, United States Of America; Liverpool, United Kingdom)
| |
Elevated body mass index is associated with preserved lung volumes and gas transfer in COPD D. Shrikrishna, J. Moxham, D. Cramer, M. I. Polkey, N. S. Hopkinson (London, United Kingdom)
| |
COPD patients exhibit abnormally increased peripheral neutrophil stiffening not different from smokers with normal lung function L. Hernández, I. Almendros, R. Rodriguez-Roísin, A. Román, R. Farré, D. Navajas (Barcelona, Spain)
| |
Antibiotic effectiveness to prevent new chronic obstructive pulmonary disease (COPD) exacerbations in current medical practice C. Mayaud, J. L. Demeaux, B. Housset, D. Peyramond, D. Pouchain, P. Blin, S. Lignot, R. Lassalle, N. Moore, M. Molimard (Paris, Bordeaux, Creteil, Lyon, Vincennes, France)
| |
Heart size and heart dysfunction in COPD – role of hyperinflation H. Watz, B. Waschki, T. Meyer, G. Kretschmar, A. Kirsten, M. Claussen, H. Magnussen (Grosshansdorf, Luebeck, Germany)
| |
Effects of n acetylcystein on proteinas-inhibitory system with chronic bronchitis O. Pavlenko, T. Pertseva, O. Lykholat (Dnepropetrovsk, Ukraine)
| |
Effects of inspiratory muscle training on dynamic hyperinflation in patients with COPD M. Petrovic, I. Werner, M. Reiter, W. Pohl, T. Wanke (Vienna, Austria)
| |
Evaluation of nutritional status in chronic obstructive pulmonary disease with bio-electric impedance T. Fatma, D. Hafaoua, K. Olfa, B. Abdelmoncef, A. Leila (Ariana, Tunis, Tunisia)
| |